BIOCAD
Roman Yanin is currently the Head of Marketing CIS Department at BIOCAD, overseeing marketing activities for oncology and autoimmune drugs within the CIS countries. With extensive experience in the pharmaceutical industry, Roman Yanin previously held positions such as Head of Marketing Oncology at R-Pharm, where promotion efforts focused on various oncology treatments, and Group Product Manager for oncology at Нанолек, leading the successful launch of the original oncohematological product Brukinsa. Other notable roles include Senior Brand Manager at AstraZeneca, Head of Rare Diseases and Oncohematology at JS Lancet, and Product Marketing Manager at Boehringer Ingelheim, where management of multiple oncology product launches took place. Roman Yanin began the career as a Product Manager at Bayer and has consistently contributed to the development and execution of marketing strategies across a diverse portfolio of oncology drugs. Educational qualifications include a Bachelor of Medicine, Bachelor of Surgery (MBBS) from Northern State Medical University.
This person is not in any teams
BIOCAD
6 followers
BIOCAD is Russia's leading innovative biotechnology company; it combines a world-class research and development center, ultra-modern pharmaceutical and biotechnological manufacturing facilities, as well as preclinical and clinical research infrastructure compliant with international standards. BIOCAD is one of the world`s few full-cycle drug development and manufacturing companies, from new molecule discovery and genetic engineering to large-scale commercial production and marketing support. BIOCAD`s medicines are dedicated to treat complex health conditions such as cancer, HIV and Hepatitis C infections, multiple sclerosis and other disorders.